Numans Health Food Holdings Company Limited provided consolidated earnings guidance for the six months ended 30 June 2025. The Group expects to record a net profit in between RMB 2.0 million to RMB 5.0 million for the Period as compared to a net profit of approximately RMB 45.3 million for the six months ended 30 June 2024. The Board believes that the aforementioned expected decrease in net profit was mainly attributable to, amongst others, (1) a significant decrease in revenue due to a consumption downgrade in the economy of the People's Republic of China (the "PRC") in general; (2) the intense competition from PRC-manufactured DHA products; and (3) decrease in other income mainly resulted from decrease in government grant.